-
DE
L50.2 is the ICD-10 code for urticaria due to cold and heat, a physical urticaria triggered by thermal stimuli causing hives and itching.
Regular tips about health Regular tips about health Add as Preferred SourceL50.2 is the ICD-10 code for urticaria due to cold and heat, a physical urticaria triggered by thermal stimuli causing hives and itching.
The ICD-10 code L50.2 refers to urticaria due to cold and heat, also known as temperature-dependent urticaria. This is a form of physical urticaria in which skin reactions – typically wheals (hives), redness, and itching – are triggered by external thermal stimuli such as cold or heat. It belongs to the group of chronic inducible urticarias.
Cold urticaria is the more common form, in which exposure to cold stimuli – such as cold air, cold water, or touching cold objects – causes the formation of wheals and swelling. Symptoms typically appear within minutes of cold contact. In severe cases, immersion in cold water can trigger a life-threatening systemic reaction (anaphylaxis).
Heat urticaria (localized heat urticaria) is triggered by direct heat contact with the skin. This form is considerably rarer than cold urticaria. Wheals develop specifically in the areas of heated skin.
The exact mechanisms are not fully understood. In cold urticaria, thermal stimuli are believed to activate mast cells in the skin, causing them to release histamine and other inflammatory mediators. Possible contributing factors include:
Typical symptoms of L50.2 include:
Diagnosis is made by a dermatologist. Typical diagnostic procedures include:
The management of L50.2 involves several approaches:
The most important principle is consistent avoidance of triggers, such as minimising contact with cold water, cold air, or intense heat.
Non-sedating H1 antihistamines (e.g. cetirizine, loratadine, bilastine, rupatadine) are the first-line treatment. They block the effects of histamine and reduce wheals and itching. If standard doses are insufficient, the dose may be increased up to fourfold according to international guidelines.
For severe or antihistamine-refractory cold urticaria, omalizumab (a monoclonal anti-IgE antibody) may be used. It is approved for chronic urticaria and has demonstrated efficacy in clinical studies.
In selected cases, gradual desensitisation to cold stimuli may be attempted under medical supervision.
The prognosis varies. In many patients, cold urticaria resolves spontaneously within a few years. Consistent treatment significantly improves quality of life. Patients with severe cold urticaria should carry an emergency allergy card and an adrenaline auto-injector at all times.
As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.
Average rating of 4.97 out of 5 stars
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, lactic acid bacteria, and Lactoferrin CLN®
Average rating of 4.85 out of 5 stars
For your universal protection
As one of the most valuable proteins in the body, lactoferrin is a natural component of the immune system.
Average rating of 4.86 out of 5 stars
Daily basic supply: the complete spectrum of micronutrients
Natural multivitamin complex for the immune system, energy, and central body functions
Average rating of 4.94 out of 5 stars
For your iron balance
Specially formulated for your iron balance with plant-based curry leaf iron, Lactoferrin CLN®, and natural Vitamin C from rose hips.